{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122 Automated Microbiology System Tetracycline 0.5-16 \u03bcg/mL",
        "BD Phoenix\u2122M Automated Microbiology System for use with Tetracycline 0.5-16 \u03bcg/mL Gram-negative and Gram-positive ID/AST or AST panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K060214",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322",
        "K024153",
        "K032131"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "March 9, 2006",
    "Summary Letter Received Date": "January 27, 2006",
    "Submission Date": "January 26, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tetracycline"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative and Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator growth detection"
    ],
    "Methodologies": [
        "Quantitative minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Instrument",
        "Panel",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System using Tetracycline panels for automated susceptibility testing of Gram-negative and Gram-positive bacterial isolates",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative aerobic and facultative anaerobic bacteria and Gram-positive bacteria isolates from pure culture for identification and/or susceptibility testing",
    "fda_folder": "Microbiology"
}